Letter in Opposition to the CLEARR Act (H.R. 2133)By NCRC / July 12, 2017 / Testimony & Regulatory Comments / 1 minute of reading online pharmacy order pepcid no prescription with best prices today in the USA Letter to Letter in Opposition to the CLEARR Act (H.R. 2133)(Download PDF)
NCRC and 100+ CDFIs Demand $324 Million in Appropriations for the CDFI Fund Testimony & Regulatory Comments
Organizations Ask Federal Reserve to Reconsider Approval of Harmful Capital One – Discover Merger Testimony & Regulatory Comments
NCRC Submits Comment Letter on HUD’s 2025 Affirmatively Furthering Fair Housing Interim Final Rule Testimony & Regulatory Comments
NCRC’s Comment on New York’s Proposed State CRA Rules for Mortgage Companies Testimony & Regulatory Comments